Literature DB >> 7998941

Lithium stimulates accumulation of second-messenger inositol 1,4,5-trisphosphate and other inositol phosphates in mouse pancreatic minilobules without inositol supplementation.

J F Dixon1, L E Hokin.   

Abstract

Previous studies showed that lithium, beginning at therapeutic plasma concentrations in the treatment of manic depression, increased the accumulation of second-messenger inositol 1,4,5-trisphosphate [Ins(1,4,5)P3] in cerebral cortex slices of guinea pig and rhesus monkey [Lee, Dixon, Reichman, Moummi, Los and Hokin (1992) Biochem. J. 282, 377-385; Dixon, Lee, Los and Hokin (1992) J. Neurochem. 59, 2332-2335; Dixon, Los and Hokin (1994) Proc. Natl. Acad. Sci. U.S.A. 91, 8358-8362]. These studies have now been extended to a peripheral tissue, mouse pancreatic minilobules. In the presence of carbachol, concentrations of lithium from 1 to 20 mM sharply and progressively increased the accumulation of Ins(1,4,5)P3 and inositol 1,3,4,5-tetrakisphosphate, followed by a decrease. Assay of these inositol polyphosphates by either the prelabelling technique or mass assay gave similar results. Atropine quenching of cholinergically stimulated pancreatic minilobules led to a rapid disappearance of Ins(1,4,5)P3. This disappearance was impeded by lithium. This suggested that the lithium-induced elevation in Ins(1,4,5)P3 was due to inhibition of the 5-phosphatase and, on the basis of the markedly elevated concentrations of inositol 1,3,4-trisphosphate [Ins(1,3,4)P3] and inositol 1,4-bisphosphate in the presence of lithium, probably by feedback inhibition by these latter two compounds. An additional mechanism, i.e. a stimulatory effect of lithium on phospholipase C, cannot, however, be ruled out. The other reaction product of phospholipase C, inositol cyclic 1:2,4,5-trisphosphate, also increased in the presence of lithium. This may also be due to inhibition of the 5-phosphatase, which is the exclusive mechanism for removal of this compound. The effects of lithium on the accumulation of other inositol phosphates paralleled that of Ins(1,4,5)P3, with the exception of inositol 3,4-bisphosphate, which decreased. This was presumably due to the inhibition of Ins(1,3,4)P3 1-phosphatase by lithium. Unlike mouse cerebral cortex slices [Lee, Dixon, Reichman, Moummi, Los and Hokin (1992) Biochem. J. 282, 377-385], inositol supplementation was not required to demonstrate lithium-stimulated Ins(1,4,5)P3 accumulation in mouse pancreatic minilobules. This indicates that inositol depletion sufficient to impair lithium-stimulated Ins(1,4,5)P3 accumulation does not occur in mouse pancreatic minilobules, even though an elevation of cytidine diphosphodiacylglycerol occurred, indicating some inositol depletion due to lithium. Elevation of Ins(1,4,5)P3 by lithium may be a general phenomenon in the central nervous system and peripheral tissues under non-rate-limiting concentrations of inositol.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7998941      PMCID: PMC1137479          DOI: 10.1042/bj3040251

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  31 in total

Review 1.  Metabolism of the inositol phosphates produced upon receptor activation.

Authors:  S B Shears
Journal:  Biochem J       Date:  1989-06-01       Impact factor: 3.857

2.  The characteristics, capacity and receptor regulation of inositol uptake in 1321N1 astrocytoma cells.

Authors:  I H Batty; A Michie; M Fennel; C P Downes
Journal:  Biochem J       Date:  1993-08-15       Impact factor: 3.857

3.  Isolation and characterization of the inositol cyclic phosphate products of phosphoinositide cleavage by phospholipase C. Metabolism in cell-free extracts.

Authors:  T M Connolly; D B Wilson; T E Bross; P W Majerus
Journal:  J Biol Chem       Date:  1986-01-05       Impact factor: 5.157

4.  Effects of lithium on phosphoinositide metabolism in vivo.

Authors:  W R Sherman; B G Gish; M P Honchar; L Y Munsell
Journal:  Fed Proc       Date:  1986-10

5.  Two dephosphorylation pathways of inositol 1,4,5-trisphosphate in homogenates of the cellular slime mould Dictyostelium discoideum.

Authors:  M M Van Lookeren Campagne; C Erneux; R Van Eijk; P J Van Haastert
Journal:  Biochem J       Date:  1988-09-01       Impact factor: 3.857

6.  Potentiation by lithium of CMP-phosphatidate formation in carbachol-stimulated rat cerebral-cortical slices and its reversal by myo-inositol.

Authors:  P P Godfrey
Journal:  Biochem J       Date:  1989-03-01       Impact factor: 3.857

Review 7.  Lithium and the phosphoinositide cycle: an example of uncompetitive inhibition and its pharmacological consequences.

Authors:  S R Nahorski; C I Ragan; R A Challiss
Journal:  Trends Pharmacol Sci       Date:  1991-08       Impact factor: 14.819

8.  Lithium enhances accumulation of [3H]inositol radioactivity and mass of second messenger inositol 1,4,5-trisphosphate in monkey cerebral cortex slices.

Authors:  J F Dixon; C H Lee; G V Los; L E Hokin
Journal:  J Neurochem       Date:  1992-12       Impact factor: 5.372

9.  Inositol 1,2-cyclic 4,5-trisphosphate concentration relative to inositol 1,4,5-trisphosphate in pancreatic minilobules on stimulation with carbamylcholine in the absence of lithium. Possible role as a second messenger in long- but not short-term responses.

Authors:  J F Dixon; L E Hokin
Journal:  J Biol Chem       Date:  1987-10-15       Impact factor: 5.157

10.  Evidence for lithium-sensitive inositol 4,5-bisphosphate accumulation in muscarinic cholinoceptor-stimulated cerebral-cortex slices.

Authors:  S Jenkinson; R A Challiss; S R Nahorski
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

View more
  6 in total

1.  p42(IP4)/centaurin alpha1, a brain-specific PtdIns(3,4,5)P3/Ins(1,3,4,5)P4-binding protein: membrane trafficking induced by epidermal growth factor is inhibited by stimulation of phospholipase C-coupled thrombin receptor.

Authors:  Fariba Sedehizade; Christoph von Klot; Theodor Hanck; Georg Reiser
Journal:  Neurochem Res       Date:  2005-10       Impact factor: 3.996

Review 2.  Pharmacogenetics in model systems: defining a common mechanism of action for mood stabilisers.

Authors:  Robin S B Williams
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2005-07       Impact factor: 5.067

Review 3.  Proof of concept trials in bipolar disorder and major depressive disorder: a translational perspective in the search for improved treatments.

Authors:  Rodrigo Machado-Vieira; Carlos A Zarate
Journal:  Depress Anxiety       Date:  2011-02-24       Impact factor: 6.505

4.  The inositol monophosphatase inhibitor L-690,330 affects pilocarpine-behavior and the forced swim test.

Authors:  Liza Shtein; Lilach Toker; Yuly Bersudsky; R H Belmaker; Galila Agam
Journal:  Psychopharmacology (Berl)       Date:  2013-01-24       Impact factor: 4.530

Review 5.  Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders.

Authors:  Gerard Sanacora; Carlos A Zarate; John H Krystal; Husseini K Manji
Journal:  Nat Rev Drug Discov       Date:  2008-05       Impact factor: 84.694

6.  IP3 accumulation and/or inositol depletion: two downstream lithium's effects that may mediate its behavioral and cellular changes.

Authors:  Y Sade; L Toker; N Z Kara; H Einat; S Rapoport; D Moechars; G T Berry; Y Bersudsky; G Agam
Journal:  Transl Psychiatry       Date:  2016-12-06       Impact factor: 6.222

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.